Author

Tanja Nickolay

Observed names: Nickolay T, T Nickolay, T. Nickolay

Institutions: Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz

Observed institutions: Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz

OpenAlex ID: A5014923902

Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial

2017 · Manfred Ballmann, Dominique Hubert, et al. · The Lancet Diabetes & Endocrinology · 71

Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease

2022 · Matthias Griese, Matthias Kappler, et al. · Orphanet Journal of Rare Diseases · 44

Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program

2019 · Markus Moehler, Annett Maderer, et al. · BMC Cancer · 41

Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial

2019 · Ballmann M, Dominique H, et al. · Yearbook of pediatric endocrinology · 2

Characteristics of children with severe preschool asthma prior to starting the TIPP study

2025 · S. Zielen, J. Wosniok, et al. · Frontiers in Pediatrics · 1

Efficacy and safety of tiotropium in partial and uncontrolled preschool asthma (TIPP): a phase III, multicentre, randomised, double-blind, placebo-controlled trial

2026 · Stefan Zielen, Nadine Wollscheid, et al. · EClinicalMedicine

Eine prospektive Studie zur Untersuchung der Wirksamkeit und Sicherheit von Tiotropium bei partiellem und unkontrolliertem Asthma im Vorschulalter (Tipp).

2026 · S Zielen, N Wollscheid, et al. · Klinische Pädiatrie

Works count: 7

Citation count: 158

H-index: 3

I10-index: 3